Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-05-10
1981-10-06
Kyle, Deborah L.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 15, 424 12, G01N 3348, G01T 100, A61K 4300, G01N 2306
Patent
active
042935369
ABSTRACT:
Estrogen receptor protein, estrophilin, in a tissue sample is detected and quantified by radiochemical methods involving selective binding of the protein to controlled pore glass beads. Also disclosed are methods for selectively removing undesirable degradation products from radiochemically labelled non-polar steroid reagents, especially estradiol.
REFERENCES:
Truong et al., Chem. Abstracts, vol. 83, No. 11, Sep. 15, 1975, Astract #93229h.
Fishman et al., J. Clin. Endocrinol, Metab., 39: 603-606 (1974).
Korenman et al., J. Clin. Endocrinol. Metab., 30: 639-645 (1970).
Hospelhorn Verne D.
Jensen Elwood V.
Kyle Deborah L.
Nucker Christine M.
University Patents Inc.
LandOfFree
Estrophilin detection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Estrophilin detection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Estrophilin detection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1206466